Score Overview
See the full market ranking โ
Evogene fundamental performance
Between 2020 and 2025, revenue grew from $ 1M to $ 3M and net income went from -$ 23M to -$ 8M. Revenue increased in 3 of those 5 years; net income in 4.
Between 2015 and 2025, revenue declined from $ 11M to $ 3M and net income went from -$ 17M to -$ 8M. Revenue increased in 4 of those 10 years; net income in 6.
Evogene currently holds a 5-year HDB Score of 6.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.61 | โ |
1 Year2025-08-12 | $ 1.25 | -51.05% |
5 Years2021-08-12 | $ 29.60 | -97.93% |
10 Years2016-08-12 | $ 67.90 | -99.10% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 |
|---|---|---|---|---|
| Price | $ 0.61 | $ 1.25 | $ 29.60 | $ 67.90 |
| Return | โ | -51.05% | -97.93% | -99.10% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 3M | -$ 8M | $ 12M |
| 2024 | $ 8M | -$ 16M | $ 15M |
| 2023 | $ 5M | -$ 23M | $ 31M |
| 2022 | $ 1M | -$ 26M | $ 35M |
| 2021 | $ 930K | -$ 27M | $ 53M |
| 2020 | $ 1M | -$ 23M | $ 48M |
| 2019 | $ 753K | -$ 18M | $ 46M |
| 2018 | $ 1M | -$ 20M | $ 54M |
| 2017 | $ 3M | -$ 20M | $ 71M |
| 2016 | $ 6M | -$ 19M | $ 88M |
| 2015 | $ 11M | -$ 17M | $ 100M |
| 2014 | $ 14M | -$ 14M | $ 115M |
| 2013 | $ 17M | -$ 8M | $ 126M |
| 2012 | $ 17M | -$ 2M | $ 55M |
| 2011 | $ 14M | $ 645K | |
| 2010 |
Explore beyond EVGN
You're looking at Evogene. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
